Patricia Ganz named editor in chief of Journal of the National Cancer Institute

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Patricia Ganz will replace Carmen Allegra as editor-in-chief of JNCI.

This move was precipitated by Allegra’s recent assignment at NCI as the head of gastrointestinal therapeutics of the Clinical Investigations Branch at the Cancer Therapy Evaluation Program. Allegra will continue at JNCI as deputy editor.

Ganz is a professor of health policy and management in the Fielding School of Public Health, and a professor of medicine in the David Geffen School of Medicine at UCLA. She also serves as director of Cancer Prevention & Control Research at UCLA’s Jonsson Comprehensive Cancer Center.

As editor-in-chief, Ganz is responsible for JNCI Monographs, a supplement publication that provides a venue for conference proceedings or topic areas where a series of related articles serve a scientific purpose.

During the past two years, JNCI has developed a series of virtual collections curated from prior publications; these thematically organized collections focus on timely selected topics and are featured online with free access for several months.

YOU MAY BE INTERESTED IN

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login